Both Semaglutide and Mounjaro represent innovative methods to treating glucose control, and increasingly, obesity. Semaglutide is a twin agonist that works on two chemicals involved in glucose regulation: GLP-1 and another incretin. Mounjaro, often viewed as a product name for Tirzepatide, functi